We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expedited Patent Reviews Changing Drugmakers’ IP Practices
Expedited Patent Reviews Changing Drugmakers’ IP Practices
A recent system for expedited review that makes it easier for challengers to overturn patents is prompting intellectual property counsel at drug and biotech companies to rethink their game plan on how and when to challenge a patent or launch a defense.